Research ArticleLetter to the Editor
Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?
Joseph A. Ware, Bradley L. Urquhart, Yuichi Sugiyama and Maciej J. Zamek-Gliszczynski
Drug Metabolism and Disposition December 2014, 42 (12) 1979-1980; DOI: https://doi.org/10.1124/dmd.114.060970
Joseph A. Ware
Clinical Pharmacology, Genentech, South San Francisco, California (J.A.W.); University of Western Ontario, London, Ontario, Canada (B.L.U.); RIKEN Innovation Center, Yokohama, Kanagawa, Japan (Y.S.); and Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina (M.J.Z.-G.)
Bradley L. Urquhart
Clinical Pharmacology, Genentech, South San Francisco, California (J.A.W.); University of Western Ontario, London, Ontario, Canada (B.L.U.); RIKEN Innovation Center, Yokohama, Kanagawa, Japan (Y.S.); and Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina (M.J.Z.-G.)
Yuichi Sugiyama
Clinical Pharmacology, Genentech, South San Francisco, California (J.A.W.); University of Western Ontario, London, Ontario, Canada (B.L.U.); RIKEN Innovation Center, Yokohama, Kanagawa, Japan (Y.S.); and Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina (M.J.Z.-G.)
Maciej J. Zamek-Gliszczynski
Clinical Pharmacology, Genentech, South San Francisco, California (J.A.W.); University of Western Ontario, London, Ontario, Canada (B.L.U.); RIKEN Innovation Center, Yokohama, Kanagawa, Japan (Y.S.); and Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina (M.J.Z.-G.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleLetter to the Editor
Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?
Joseph A. Ware, Bradley L. Urquhart, Yuichi Sugiyama and Maciej J. Zamek-Gliszczynski
Drug Metabolism and Disposition December 1, 2014, 42 (12) 1979-1980; DOI: https://doi.org/10.1124/dmd.114.060970
Research ArticleLetter to the Editor
Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?
Joseph A. Ware, Bradley L. Urquhart, Yuichi Sugiyama and Maciej J. Zamek-Gliszczynski
Drug Metabolism and Disposition December 1, 2014, 42 (12) 1979-1980; DOI: https://doi.org/10.1124/dmd.114.060970
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement